HIGHLIGHTS
- who: Inhibitor and collaborators from the School of Pharmacy, National Taiwan University, Taipei, Taiwan, Department of Pharmacy, Taipei Municipal TuCheng have published the research work: The Combination of a Novel GLUT1 Inhibitor and Cisplatin Synergistically Inhibits Breast Cancer Cell Growth By Enhancing the DNA Damaging Effect and Modulating the Akt/mTOR and MAPK Signaling Pathways, in the Journal: (JOURNAL)
- what: The authors report that #43 enhances the cytotoxic effect of cisplatin against breast cancer cells by augmenting its DNA damaging effect. 2-NBDG uptake assay followed by flow cytometric analysis was conducted to determine the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.